首页> 外文期刊>Annals of Oncology >Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases
【24h】

Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases

机译:切除的I期非小细胞肺癌(NSCLC)纵隔淋巴结中分子标志物的表达:预后的影响和潜在的隐匿性微转移标志物的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Occult lymph node (LN) metastases are clinically relevant and confer a worse prognosis in non-small-cell lung cancer (NSCLC) patients. Current staging methods are unable to identify patients with poor outcome. Their detection requires both a more sensitive and specific technique. We aimed to assess the role of messenger RNA expression in pathologically negative LNs (pN0) of stage I NSCLC patients as markers of occult micrometastases and to correlate the results with local or distant tumor recurrence and survival.
机译:背景:隐匿性淋巴结转移与临床相关,在非小细胞肺癌(NSCLC)患者中预后较差。当前的分期方法无法确定预后不良的患者。对它们的检测既需要更灵敏又需要特定的技术。我们旨在评估信使RNA表达在I期NSCLC患者病理阴性LNs(pN0)中的作用,作为隐匿性微转移的标志物,并将结果与​​局部或远处肿瘤的复发和生存相关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号